Laurie Myers
Chief Operating Officer at CINGULATE INC.
Net worth: 2 028 $ as of 29/04/2024
Profile
Laurie A.
Myers is currently the Chief Operating Officer at Cingulate Therapeutics LLC, Chief Operating Officer & Executive Vice President at Cingulate Works, Inc., and Chief Operating Officer & Executive VP at Cingulate, Inc. Previously, she worked as the Head-Marketing at Fidia Pharma USA, Inc. Dr. Myers holds an MBA from St. Joseph's University, undergraduate and graduate degrees from the University of Scranton, and a doctorate from New Jersey Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CINGULATE, INC.
0.06% | 14/04/2024 | 2,414 ( 0.06% ) | 2 028 $ | 29/04/2024 |
Laurie Myers active positions
| Companies | Position | Start |
|---|---|---|
| CINGULATE INC. | Chief Operating Officer | 31/03/2017 |
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Chief Operating Officer | 31/10/2017 |
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Chief Operating Officer | 31/03/2017 |
Former positions of Laurie Myers
| Companies | Position | End |
|---|---|---|
Fidia Pharma USA, Inc.
 Fidia Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Part of P.&R. The company is based in Parsippany, NJ. The website is intended for use by US residents only. S.p.A, Fidia Pharma USA, Inc. is a pharmaceutical company. The company's product portfolio includes hyaluronic acid-based viscosupplement products. Fidia is committed to compliantly assisting its customers to ensure a smooth transition from WAC-based to ASP-based reimbursement. Fidia Pharma USA is a wholly owned subsidiary of Fidia Farmaceutici S.p.A, which was founded in 1946. | Sales & Marketing | 31/10/2017 |
Training of Laurie Myers
| St. Joseph's University | Masters Business Admin |
| University of Scranton | Graduate Degree |
| New Jersey Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CINGULATE INC. | Health Technology |
| Private companies | 3 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
Fidia Pharma USA, Inc.
Fidia Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Part of P.&R. The company is based in Parsippany, NJ. The website is intended for use by US residents only. S.p.A, Fidia Pharma USA, Inc. is a pharmaceutical company. The company's product portfolio includes hyaluronic acid-based viscosupplement products. Fidia is committed to compliantly assisting its customers to ensure a smooth transition from WAC-based to ASP-based reimbursement. Fidia Pharma USA is a wholly owned subsidiary of Fidia Farmaceutici S.p.A, which was founded in 1946. | Health Technology |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
- Stock Market
- Insiders
- Laurie Myers